FDA Orange Book
Generic for Cordran
Cordran contains flurandrenolide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Cordran is flurandrenolide. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Generics match 2 of the 4 Cordran products the Orange Book lists.
Run it in Rivvi
Map Cordran and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Cordran products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| lotion, topical | 0.05% | Discontinued | None | 1 | None |
| ointment, topical | 0.025% | Discontinued | None | 0 | None |
| ointment, topical | 0.05% | Discontinued | None | 1 | None |
| tape, topical | 0.004MG/SQ CM | Marketed (Rx) | None | 0 | None |
NDA 013790, 012806, 016455, held by INA PHARMACEUTICS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic flurandrenolide
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| PADAGIS ISRAEL PHARMACEUTICALS LTD | 207133 | None (No TE code listed) | August 30, 2016 | 0.05% |
| TELIGENT PHARMA INC | 207851 | None (No TE code listed) | December 30, 2016 | 0.05% |
Cordran NDC codes
Questions
Is there a generic for Cordran?
Yes. The generic name for Cordran is flurandrenolide. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Generics match 2 of the 4 Cordran products the Orange Book lists.
What is the generic name for Cordran?
The active ingredient in Cordran is flurandrenolide, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.